Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 5/20 | 1.00 |
| ▸ | ACHE | P22303 | 4/20 | 1.00 |
| ▸ | MGAM | O43451 | 1/20 | 1.00 |
| ▸ | SI | P14410 | 1/20 | 1.00 |
| ▸ | PTPN1 | P18031 | 1/20 | 1.00 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 1.00 |
| ▸ | MAOA | P21397 | 1/20 | 0.65 |
| ▸ | NPC1 | O15118 | 2/20 | 0.57 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.56 |
| ▸ | HPGD | P15428 | 10/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | RAB9A | P51151 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | CA9 | Q16790 | 3/20 | 0.48 |
| ▸ | CA12 | O43570 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Decursinol SCHEMBL14105325 | 1.00 | GAA (1.00) | GAAACHEMGAMSIPTPN1 | |
| Decursinol SCHEMBL30034733 | 1.00 | GAA (1.00) | GAAACHEMGAMSIPTPN1 | |
| Decursinol SCHEMBL29517185 | 1.00 | GAA (1.00) | GAAACHEMGAMSIPTPN1 | |
| Decursinol SCHEMBL18845442 | 1.00 | GAA (1.00) | GAAACHEMGAMSIPTPN1 | |
| SCHEMBL14105337 | 0.86 | GAA (0.76) | GAAACHEMGAMSIPTPN1 | |
| SCHEMBL23983278 | 0.83 | GAA (0.71) | GAAACHEMGAMSIPTPN1 | |
| SCHEMBL14303567 | 0.82 | MAOA (0.79) | GAAACHEMGAMSIPTPN1 | |
| SCHEMBL4740846 | 0.82 | MAOA (0.79) | GAAACHEMGAMSIPTPN1 | |
| SCHEMBL15444405 | 0.80 | MAOA (0.67) | GAAACHEMGAMSIPTPN1 | |
| Decursin SCHEMBL14511556 | 0.80 | MAOA (1.00) | GAAACHEMGAMSIPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1169034-A4 | DECURSINOL OR DERIVATIVE THEREOF AS ANALGESIC AGENT | SCIGENIC CO LTD (KR) | 2009-03-18 | — | — | EP | claimed |
| EP-1169034-A1 | DECURSINOL OR DERIVATIVE THEREOF AS ANALGESIC AGENT | Scigenic Co., Ltd. (KR) | 2002-01-09 | — | — | EP | claimed |
| WO-2001052841-A1 | DECURSINOL OR DERIVATIVE THEREOF AS ANALGESIC AGENT | SCIGENIC CO., LTD. (KR) | 2001-07-26 | — | — | WO | claimed |
| WO-2024043354-A1 | METHOD FOR PRODUCING ANGELICA GIGANTIS RADIX EXTRACT CONTAINING ULTRA-FINE DECURSIN CRYSTALS | (주)메디언스 | 2024-02-29 | — | — | WO | disclosed |
| US-20220118064-A1 | MULTI-SUPPLEMENT COMPOSITIONS | MELALEUCA, INC. | 2022-04-21 | — | — | US | disclosed |
| EP-3973972-A1 | MULTI-SUPPLEMENT COMPOSITIONS | Melaleuca, Inc. (US) | 2022-03-30 | — | — | EP | disclosed |
| US-11207388-B2 | Multi-supplement compositions | MELALEUCA, INC. (US) | 2021-12-28 | — | — | US | disclosed |
| US-20210100863-A1 | DIETARY SUPPLEMENTS AND METHODS FOR TREATING PAIN AND INFLAMMATION | MELALEUCA, INC. | 2021-04-08 | — | — | US | disclosed |
| US-10653734-B2 | Dietary supplements and methods for treating pain and inflammation | MELALEUCA, INC. (US) | 2020-05-19 | — | — | US | disclosed |
| US-20170095519-A1 | DIETARY SUPPLEMENTS AND METHODS FOR TREATING PAIN AND INFLAMMATION | MELALEUCA, INC. | 2017-04-06 | — | — | US | disclosed |
| WO-2016109856-A1 | MULTI-SUPPLEMENT COMPOSITIONS | MELALEUCA, INC. (US) | 2016-07-07 | — | — | WO | disclosed |
| US-20160193306-A1 | MULTI-SUPPLEMENT COMPOSITIONS | MELALEUCA, INC. | 2016-07-07 | — | — | US | disclosed |
| US-9352008-B2 | Dietary supplements and methods for treating pain and inflammation | MELALEUCA, INC. (US) | 2016-05-31 | — | — | US | disclosed |
| WO-2011019867-A2 | DIETARY SUPPLEMENTS AND METHODS FOR TREATING PAIN AND INFLAMMATION | MELALEUCA, INC. (US) | 2011-02-17 | — | — | WO | disclosed |
| WO-2010064817-A2 | NOVEL COUMARIN-BASED COMPOUNDS, PREPARATION METHOD THEREOF, AND MULTIDRUG RESISTANCE INHIBITORY PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AS ACTIVE INGREDIENTS | 한국생명공학연구원 (KR) | 2010-06-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170095519-A1 | DIETARY SUPPLEMENTS AND METHODS FOR TREATING PAIN AND INFLAMMATION | COL2A1, CXCL8, IL6 | GAA 4074/4885ACHE 39/4885MGAM 1112/4885 |
| US-11207388-B2 | Multi-supplement compositions | SLC5A6, FABP2, GLS2 | GAA 2099/4885ACHE 1408/4885MGAM 1093/4885 |
| US-20160193306-A1 | MULTI-SUPPLEMENT COMPOSITIONS | SLC5A6, FABP2, GLS2 | GAA 2099/4885ACHE 1408/4885MGAM 1093/4885 |
| US-10653734-B2 | Dietary supplements and methods for treating pain and inflammation | COL2A1, CXCL8, IL6 | GAA 4074/4885ACHE 39/4885MGAM 1112/4885 |
| US-20210100863-A1 | DIETARY SUPPLEMENTS AND METHODS FOR TREATING PAIN AND INFLAMMATION | COL2A1, CXCL8, IL6 | GAA 4074/4885ACHE 39/4885MGAM 1112/4885 |
| US-20220118064-A1 | MULTI-SUPPLEMENT COMPOSITIONS | SLC5A6, FABP2, GLS2 | GAA 2099/4885ACHE 1408/4885MGAM 1093/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.